Given that both nuclear and cytosolic WBP2 have defined molecular functions in the Hippo pathway, we postulate that directing WBP2 cellular localization is not a tenable anti-cancer avenue to modulate the Hippo pathway. The gene discussed is WBP2; the disease is cancer.